We are live on
!
Find out more
AssetMark Inc Portfolio holdings
AUM
$58.2B
1-Year Est. Return
22.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+22.78%
3 Year Est. Return
+68.16%
5 Year Est. Return
+68.87%
10 Year Est. Return
+243.14%
AUM
$49B
AUM Growth
+$2.39B
(+5.1%)
Cap. Flow
+$1.76B
Cap. Flow
% of AUM
3.59%
Top 10 Holdings %
Top 10 Hldgs %
28.8%
Holding
3,493
New
313
Increased
1,545
Reduced
929
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$561M |
| 2 |
Newmont
NEM
|
+$207M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$79.6M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$72.9M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra S&P500
SSO
|
+$561M |
| 2 |
iShares MSCI Europe Financials ETF
EUFN
|
+$80.7M |
| 3 |
iShares Global Infrastructure ETF
IGF
|
+$79.6M |
| 4 |
Vistra
VST
|
+$71.2M |
| 5 |
Sprouts Farmers Market
SFM
|
+$63.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.57% |
| 2 | Communication Services | 5.61% |
| 3 | Financials | 5.55% |
| 4 | Healthcare | 3.51% |
| 5 | Consumer Discretionary | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Guardant Health
GH
$22.6B
| $2.01M | ﹤0.01% |
19,718
+6,461
| +49% | +$578K |
|
|
CPRX
852
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.01M | ﹤0.01% |
86,137
-3,172
| -4% | -$70.7K |
|
853
NatWest
NWG
$76.4B
| $2.01M | ﹤0.01% |
114,747
-12,443
| -10% | -$197K |
|
854
Capital Group Core Plus Income ETF
CGCP
$8.44B
| $2M | ﹤0.01% |
88,313
+44,238
| +100% | +$1.01M |
|
855
AES
AES
$10.5B
| $1.99M | ﹤0.01% |
138,488
+14,456
| +12% | +$204K |
|
856
Crown Castle
CCI
$32.1B
| $1.97M | ﹤0.01% |
22,166
-480
| -2% | -$44.1K |
|
857
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
| $1.96M | ﹤0.01% |
14,353
-155
| -1% | -$20.3K |
|
|
CGIB
858
Capital Group International Bond ETF USD-Hedged
CGIB
$298M
| $1.96M | ﹤0.01% |
77,133
+38,090
| +98% | +$970K |
|
859
First Trust Long Duration Opportunities ETF
LGOV
$622M
| $1.93M | ﹤0.01% |
88,612
-8,304
| -9% | -$183K |
|
860
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.1B
| $1.93M | ﹤0.01% |
37,931
+5,586
| +17% | +$285K |
|
|
CGCV
861
Capital Group Conservative Equity ETF
CGCV
$2.01B
| $1.92M | ﹤0.01% |
62,866
+7,684
| +14% | +$233K |
|
|
CGIC
862
Capital Group International Core Equity ETF
CGIC
$2.31B
| $1.9M | ﹤0.01% |
58,579
+36,700
| +168% | +$1.16M |
|
863
Incyte
INCY
$24.4B
| $1.9M | ﹤0.01% |
19,202
+17,307
| +913% | +$1.67M |
|
864
Nuveen ESG Emerging Markets Equity ETF
NUEM
$384M
| $1.9M | ﹤0.01% |
53,298
+2,559
| +5% | +$93.1K |
|
865
Johnson Controls International
JCI
$92.2B
| $1.89M | ﹤0.01% |
15,824
+674
| +4% | +$77.4K |
|
866
Chewy
CHWY
$9.63B
| $1.89M | ﹤0.01% |
57,060
-3,316
| -5% | -$115K |
|
867
Southern Company
SO
$107B
| $1.89M | ﹤0.01% |
21,625
-1,083
| -5% | -$98.9K |
|
868
iShares MSCI EAFE Growth ETF
EFG
$17.3B
| $1.87M | ﹤0.01% |
16,452
+742
| +5% | +$85.1K |
|
869
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
| $1.86M | ﹤0.01% |
20,391
+84
| +0.4% | +$7.55K |
|
870
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $1.85M | ﹤0.01% |
19,420
-3,061
| -14% | -$289K |
|
871
Nike
NKE
$61.9B
| $1.85M | ﹤0.01% |
28,966
+9,868
| +52% | +$643K |
|
872
Jazz Pharmaceuticals
JAZZ
$16.7B
| $1.84M | ﹤0.01% |
10,848
+5,499
| +103% | +$843K |
|
873
ING
ING
$102B
| $1.84M | ﹤0.01% |
65,859
+9,512
| +17% | +$245K |
|
874
Pegasystems
PEGA
$5.38B
| $1.84M | ﹤0.01% |
30,875
-1,199
| -4% | -$70.2K |
|
875
Ascendis Pharma A/S
ASND
$16.8B
| $1.83M | ﹤0.01% |
8,579
+2,787
| +48% | +$576K |
|
Similar funds
NAMI
AssetMark Inc's Q4 2025 Portfolio in Review
As of Q4 2025, AssetMark Inc held 3,493 positions worth $49B, up 5.1% from $46.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
AssetMark Inc deployed $1.76B of net new capital in Q4 2025, opening 313 new positions and adding to 1,545 existing holdings. Its largest new stake was Akre Focus ETF: 554,566 shares worth $36.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was ProShares Ultra S&P500, an estimated $561M trimmed.
- AssetMark Inc's largest Q4 2025 buy was Akre Focus ETF: 554,566 shares worth $36.3M.
- AssetMark Inc added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $561M increase.
- AssetMark Inc's biggest Q4 2025 reduction was ProShares Ultra S&P500, cutting an estimated $561M.
- AssetMark Inc fully exited Hanesbrands in Q4 2025, selling an estimated $3.46M.
- AssetMark Inc's ten largest holdings make up 29% of its $49B portfolio in Q4 2025.
- AssetMark Inc opened 313 new positions and closed 124 in Q4 2025.
- AssetMark Inc's portfolio value rose 5.1% quarter-over-quarter to $49B.
Based on AssetMark Inc's 13F filing for Q4 2025, filed 23 Jan 2026.